Feasibility of dendritic cell-based vaccine against glioblastoma by using cytoplasmic transduction peptide (CTP)-fused protein antigens combined with anti-PD1
Author:
Affiliation:
1. Brain Tumor Research Laboratory
2. Departments of Neurosurgery
3. Research Center for Caner Immunotherapy
4. Department of Internal Medicine, Chonnam National University Medical School and Hwasun Hospital, Hwasun-gun, Republic of Korea
Funder
Chonnam National University Hwasun Hospital Research Institute of Clinical Medicine
Basic Science Research Program through the National Research Foundation of Korea (NRF), funded by the Ministry of Science, ICT, & Future Planning
Publisher
Informa UK Limited
Subject
Pharmacology,Immunology,Immunology and Allergy
Link
https://www.tandfonline.com/doi/pdf/10.1080/21645515.2020.1732165
Reference35 articles.
1. CBTRUS Statistical Report: Primary brain and other central nervous system tumors diagnosed in the United States in 2010–2014
2. Radiotherapy plus Concomitant and Adjuvant Temozolomide for Glioblastoma
3. Vaccine-based immunotherapy for glioblastoma
4. A Randomized Double-Blind Placebo-Controlled Phase II Trial of Dendritic Cell Vaccine ICT-107 in Newly Diagnosed Patients with Glioblastoma
5. Understanding MHC Class I Presentation of Viral Antigens by Human Dendritic Cells as a Basis for Rational Design of Therapeutic Vaccines
Cited by 5 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Wilms’ tumor 1 -targeting cancer vaccine: Recent advancements and future perspectives;Human Vaccines & Immunotherapeutics;2023-12-26
2. Human dendritic cell subsets in the glioblastoma-associated microenvironment;Journal of Neuroimmunology;2023-10
3. Effect of CTP-mediated PTEN on 5637 bladder cancer cells and the underlying molecular mechanism;BMC Urology;2022-12-10
4. The transcription factor ZNF148 promotes the malignant transformation of dendritic cells after cross-talk with glioma stem cells by upregulating PTX3;2022-11-21
5. Pharmacological combination of nivolumab with dendritic cell vaccines in cancer immunotherapy: An overview;Pharmacological Research;2021-02
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3